| Literature DB >> 35148231 |
Keerati Joyjamras1,2, Chatchai Chaotham2,3, Pithi Chanvorachote2,4.
Abstract
CONTEXT: Sericin, a protein found in wastewater from the silk industry, was shown to contain a variety of biological activities, including antioxidant. The enzymatic conditions have been continuously modified to improve antioxidant effect and scavenging capacity against various free radicals of silk sericin protein.Entities:
Keywords: Alcalase®; RSM; Waste product; antioxidant
Mesh:
Substances:
Year: 2022 PMID: 35148231 PMCID: PMC8843116 DOI: 10.1080/13880209.2022.2032208
Source DB: PubMed Journal: Pharm Biol ISSN: 1388-0209 Impact factor: 3.503
Optimum enzymatic condition following manufacturer’s instructions.
| Protease enzyme | Factors | |||
|---|---|---|---|---|
| pH | E/S (w/w) | Temperature (°C) | Time (h) | |
| Alcalase® | 8 | 2 | 60 | 3 |
| Papain | 7 | 2 | 60 | 3 |
| Trypsin | 8 | 2 | 40 | 3 |
E/S: Enzyme/Substrate ratio.
Independent variables and their levels in Box–Behnken design.
| Variables | Code | Level and range | ||
|---|---|---|---|---|
| −1 | 0 | 1 | ||
| pH | A | 7 | 8 | 9 |
| E/S (w/w) | B | 1 | 2 | 3 |
| Temperature (°C) | C | 50 | 60 | 70 |
E/S: Enzyme/Substrate ratio.
Figure 1.Distribution of protein composition in sericin hydrolysates prepared from different commercial enzymes in SDS-PAGE analysis.
Antioxidant activity of hydrolysed silk sericin from various proteases.
| Protease Enzyme | Factors | Response variable | |||||
|---|---|---|---|---|---|---|---|
| pH | E/S (w/w) | Temperature (°C) | Time (h) | DPPH | FRAP value | ORAC value | |
| - (Unhydrolysed sericin) | – | – | – | – | 9.43 ± 0.10 | 327.50 ± 11.87 | 2,767.72 ± 30.97 |
| Alcalase® | 8 | 2 | 60 | 3 | 19.71 ± 0.13 | 435.50 ± 10.13 | 4,383.92 ± 12.23 |
| Papain | 7 | 2 | 60 | 3 | 12.64 ± 0.16 | 274.68 ± 10.47 | 3,897.33 ± 23.64 |
| Trypsin | 8 | 2 | 40 | 3 | 14.43 ± 0.09 | 284.51 ± 6.46 | 4,026.85 ± 20.17 |
E/S: Enzyme/Substrate ratio, TE: Trolox equivalence.
aObtained from three independent experiments.
Box–Behnken factorial design of enzymatic hydrolysis and antioxidant response.
| Run | Independent variables | Responses | ||||
|---|---|---|---|---|---|---|
| A: pH | B: E/S (w/w) | C: Temperature (°C) | Y1: DPPH | Y2: FRAP (µmol Fe2+ eq./mg sample) | Y3: ORAC (µmol TE/mg sample) | |
| 1 | 9 | 2 | 70 | 14.67 | 455.93 | 4,591.43 |
| 2 | 7 | 2 | 70 | 20.37 | 449.07 | 4,504.01 |
| 3 | 8 | 3 | 70 | 18.89 | 422.03 | 4,156.45 |
| 4 | 8 | 2 | 60 | 14.83 | 439.90 | 4,086.49 |
| 5 | 8 | 1 | 50 | 12.86 | 364.41 | 3,617.85 |
| 6 | 8 | 2 | 60 | 14.69 | 433.76 | 4,073.43 |
| 7 | 9 | 3 | 60 | 11.21 | 383.05 | 4,052.36 |
| 8 | 8 | 3 | 50 | 14.61 | 404.24 | 3,568.68 |
| 9 | 9 | 2 | 50 | 13.37 | 376.95 | 3,805.73 |
| 10 | 7 | 3 | 60 | 16.87 | 414.41 | 3,908.42 |
| 11 | 8 | 2 | 60 | 14.71 | 443.90 | 4,086.49 |
| 12 | 7 | 1 | 60 | 13.58 | 362.03 | 4,142.16 |
| 13 | 8 | 2 | 60 | 14.15 | 442.04 | 4,097.94 |
| 14 | 9 | 1 | 60 | 14.20 | 445.76 | 4,283.99 |
| 15 | 7 | 2 | 50 | 12.86 | 368.64 | 3,696.03 |
| 16 | 8 | 1 | 70 | 18.31 | 452.54 | 4,597.03 |
| 17 | 8 | 2 | 60 | 14.37 | 449.32 | 4,064.59 |
E/S: Enzyme/Substrate ratio, TE: Trolox equivalence.
ANOVA for quadratic model of DPPH response.
| Source | Sum of Squares | df | Mean Square | F-value | |
|---|---|---|---|---|---|
| Model | 87.88 | 9 | 9.76 | 72.96 | <0.0001* |
| pH (A) | 13.08 | 1 | 13.08 | 97.75 | <0.0001* |
| E/S (B) | 0.8671 | 1 | 0.8671 | 6.48 | 0.0384* |
| Temperature (C) | 42.94 | 1 | 42.94 | 320.87 | <0.0001* |
| AB | 9.85 | 1 | 9.85 | 73.57 | <0.0001* |
| AC | 9.67 | 1 | 9.67 | 72.23 | <0.0001* |
| BC | 0.3439 | 1 | 0.3439 | 2.57 | 0.1530 |
| A² | 2.17 | 1 | 2.17 | 16.19 | 0.0050* |
| B² | 0.0740 | 1 | 0.0740 | 0.5526 | 0.4814 |
| C² | 9.28 | 1 | 9.28 | 69.32 | <0.0001* |
| Residual | 0.9368 | 7 | 0.1338 | ||
| Lack of Fit | 0.6191 | 3 | 0.2064 | 2.60 | 0.1895 |
| Pure Error | 0.3177 | 4 | 0.0794 | ||
| Cor Total | 88.82 | 16 | |||
| R² | 0.9895 | ||||
| Adjusted R² | 0.9759 | ||||
| Predicted R² | 0.8829 | ||||
| Adeq Precision | 32.1496 | ||||
| C.V.% | 2.44 |
E/S: Enzyme/Substrate ratio, *p < 0.05.
ANOVA for quadratic model of FRAP response.
| Source | Sum of Squares | df | Mean Square | F-value | |
|---|---|---|---|---|---|
| Model | 18183.51 | 9 | 2020.39 | 19.97 | 0.0003* |
| pH (A) | 570.29 | 1 | 570.29 | 5.64 | 0.0493* |
| E/S (B) | 0.1283 | 1 | 0.1283 | 0.0013 | 0.9726 |
| Temperature (C) | 8800.69 | 1 | 8800.69 | 87.00 | <0.0001* |
| AB | 3311.35 | 1 | 3311.35 | 32.74 | 0.0007* |
| AC | 0.5211 | 1 | 0.5211 | 0.0052 | 0.9448 |
| BC | 1236.89 | 1 | 1236.89 | 12.23 | 0.0100* |
| A² | 1570.61 | 1 | 1570.61 | 15.53 | 0.0056* |
| B² | 1884.83 | 1 | 1884.83 | 18.63 | 0.0035* |
| C² | 406.13 | 1 | 406.13 | 4.01 | 0.0851 |
| Residual | 708.09 | 7 | 101.16 | ||
| Lack of Fit | 578.82 | 3 | 192.94 | 5.97 | 0.0585 |
| Pure Error | 129.27 | 4 | 32.32 | ||
| Cor Total | 18891.59 | 16 | |||
| R² | 0.9625 | ||||
| Adjusted R² | 0.9143 | ||||
| Predicted R² | 0.4991 | ||||
| Adeq Precision | 13.1588 | ||||
| C.V.% | 2.41 |
E/S: Enzyme/Substrate ratio, *p < 0.05.
ANOVA for quadratic model of ORAC response.
| Source | Sum of Squares | df | Mean Square | F-value | |
|---|---|---|---|---|---|
| Model | 1.48 × 106 | 9 | 1.65 × 105 | 636.50 | <0.0001* |
| pH (A) | 29148.25 | 1 | 29148.25 | 112.31 | <0.0001* |
| E/S (B) | 1.14 × 105 | 1 | 1.14 × 105 | 439.39 | <0.0001* |
| Temperature (C) | 1.24 × 106 | 1 | 1.24 × 106 | 4811.45 | <0.0001* |
| AB | 1.11 | 1 | 1.11 | 0.0043 | 0.9497 |
| AC | 124.03 | 1 | 124.03 | 0.4779 | 0.5116 |
| BC | 38301.75 | 1 | 38301.75 | 147.58 | <0.0001* |
| A² | 33820.70 | 1 | 33820.70 | 130.32 | <0.0001* |
| B² | 23480.70 | 1 | 23480.70 | 90.48 | <0.0001* |
| C² | 2058.09 | 1 | 2058.09 | 7.93 | 0.0259* |
| Residual | 1816.69 | 7 | 259.53 | ||
| Lack of Fit | 1146.02 | 3 | 382.01 | 2.28 | 0.2215 |
| Pure Error | 670.67 | 4 | 167.67 | ||
| Cor Total | 1.48 × 106 | 16 | |||
| R² | 0.9988 | ||||
| Adjusted R² | 0.9972 | ||||
| Predicted R² | 0.9870 | ||||
| Adeq Precision | 83.4263 | ||||
| C.V.% | 0.40 |
E/S: Enzyme/Substrate ratio, *p < 0.05.
Figure 2.Response surface plots depicting the effects of pH, enzyme/substrate ratio (E/S) and temperature on antioxidant activity of sericin hydrolysates prepared by using Alcalase® against (a–c) DPPH free radicals, (d–f) ferric ions (Fe3+) and (g–i) peroxyl radicals.
Antioxidant activity of sericin hydrolysed by Alcalase® under RSM-optimized condition.
| Optimized condition | Response | Predicted value | Observed value | % Error |
|---|---|---|---|---|
| pH: 7.5, | DPPH (% Inhibition) | 19.14 | 18.65 ± 0.21 | 2.56 |
| FRAP (µmol Fe2+ eq./mg sample) | 455.93 | 462.31 ± 10.82 | 1.40 | |
| ORAC (µmol TE/mg sample) | 4,532.23 | 3,811.00 ± 39.37 | 15.91 |
E/S: Enzyme/Substrate ratio, TE: Trolox equivalence.
aObtained from three independent experiments.
Figure 3.Cellular antioxidant activity of sericin hydrolysates prepared from Alcalase® under RSM-optimized conditions. The alteration of cellular ROS levels is presented in flow cytometry histograms of (a) human keratinocyte HaCaT and (c) human melanin-generating MNT1 cells stained with DCFH2-DA fluorescence probe. Preculture with 5 mM N-acetyl cysteine (NAC), 20 mg/mL unhydrolysed sericin (UHS) or 20 mg/mL RSM-optimized sericin hydrolysates (SH) obviously diminished the relative ROS levels in (b) keratinocytes and (d) MNT1 cells after exposure to 1 mM hydrogen peroxide (H2O2) for 30 min. Data are presented as means ± SEM from three independent experiments. *p < 0.05 compared with untreated control cells. #p < 0.05 compared with the cells treated only with H2O2.
Figure 4.Molecular weight distribution of protein composition in unhydrolysed sericin and sericin hydrolysates prepared by using Alcalase® under RSM-optimized condition in (a) SDS-PAGE analysis and (b) FPLC coupled with HiPrep 16/60 Sephacryl S-200 HR column.